6-127981272-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_002844.4(PTPRK):āc.3555C>Gā(p.Thr1185Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00263 in 1,613,296 control chromosomes in the GnomAD database, including 127 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.014 ( 70 hom., cov: 32)
Exomes š: 0.0014 ( 57 hom. )
Consequence
PTPRK
NM_002844.4 synonymous
NM_002844.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.57
Genes affected
PTPRK (HGNC:9674): (protein tyrosine phosphatase receptor type K) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP mu (MAM) domain, an Ig-like domain and four fibronectin type III-like repeats. This PTP was shown to mediate homophilic intercellular interaction, possibly through the interaction with beta- and gamma-catenin at adherens junctions. Expression of this gene was found to be stimulated by TGF-beta 1, which may be important for the inhibition of keratinocyte proliferation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 6-127981272-G-C is Benign according to our data. Variant chr6-127981272-G-C is described in ClinVar as [Benign]. Clinvar id is 792053.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.57 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0143 (2170/151852) while in subpopulation AFR AF= 0.05 (2068/41368). AF 95% confidence interval is 0.0482. There are 70 homozygotes in gnomad4. There are 1031 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2170 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPRK | NM_002844.4 | c.3555C>G | p.Thr1185Thr | synonymous_variant | 25/30 | ENST00000368226.9 | NP_002835.2 | |
PTPRK | NM_001291981.2 | c.3621C>G | p.Thr1207Thr | synonymous_variant | 28/33 | NP_001278910.1 | ||
PTPRK | NM_001135648.3 | c.3573C>G | p.Thr1191Thr | synonymous_variant | 26/31 | NP_001129120.1 | ||
PTPRK | NM_001291984.2 | c.3552C>G | p.Thr1184Thr | synonymous_variant | 25/30 | NP_001278913.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPRK | ENST00000368226.9 | c.3555C>G | p.Thr1185Thr | synonymous_variant | 25/30 | 1 | NM_002844.4 | ENSP00000357209.4 |
Frequencies
GnomAD3 genomes AF: 0.0143 AC: 2165AN: 151734Hom.: 70 Cov.: 32
GnomAD3 genomes
AF:
AC:
2165
AN:
151734
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00368 AC: 922AN: 250402Hom.: 21 AF XY: 0.00264 AC XY: 357AN XY: 135376
GnomAD3 exomes
AF:
AC:
922
AN:
250402
Hom.:
AF XY:
AC XY:
357
AN XY:
135376
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00141 AC: 2067AN: 1461444Hom.: 57 Cov.: 31 AF XY: 0.00128 AC XY: 930AN XY: 727012
GnomAD4 exome
AF:
AC:
2067
AN:
1461444
Hom.:
Cov.:
31
AF XY:
AC XY:
930
AN XY:
727012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0143 AC: 2170AN: 151852Hom.: 70 Cov.: 32 AF XY: 0.0139 AC XY: 1031AN XY: 74188
GnomAD4 genome
AF:
AC:
2170
AN:
151852
Hom.:
Cov.:
32
AF XY:
AC XY:
1031
AN XY:
74188
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 24, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at